SCHEMBL2108365

SCHEMBL2108365

CCn1c2ccccc2c2cc(C(c3ccc4c(c3)c3cc(Cl)ccc3n4CC)c3ccc4c(c3)c3cc(Cl)ccc3n4CC)ccc21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.55
TP53 P04637 3/20 0.55
KDM4E B2RXH2 5/20 0.54
TDP1 Q9NUW8 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
HTT P42858 2/20 0.54
MAPK1 P28482 2/20 0.54
ALDH1A1 P00352 2/20 0.54
HPGD P15428 1/20 0.54
HBB P68871 1/20 0.54
HSD17B10 Q99714 1/20 0.54
PTGER4 P35408 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
SRC P12931 2/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL253310 0.91 MAPT (0.63) MAPTTP53KDM4ETDP1MEN1
SCHEMBL1921288 0.89 MAPT (0.65) MAPTTP53KDM4ETDP1MEN1
SCHEMBL29643271 0.89 MAPT (0.65) MAPTTP53KDM4ETDP1MEN1
SCHEMBL3156176 0.87 MAPT (0.58) MAPTTP53KDM4ETDP1MEN1
SCHEMBL27825721 0.81 MAPT (0.67) MAPTTP53KDM4ETDP1MEN1
SCHEMBL1921261 0.81 PTGER4 (0.72) MAPTTP53KDM4ETDP1MEN1
SCHEMBL4635172 0.81 MAPT (0.51) MAPTTP53KDM4ETDP1MEN1
SCHEMBL8232713 0.80 MAPT (0.61) MAPTTP53KDM4ETDP1MEN1
SCHEMBL14037008 0.80 MAPT (0.57) MAPTTP53KDM4ETDP1MEN1
SCHEMBL10666862 0.80 TP53 (0.60) MAPTTP53KDM4ETDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7211118-B2 Composition for dyeing keratin fibers comprising a defined triheteroylmethane direct dye or leuco precursor of this dye and dyeing method using it L'OREAL S.A. (FR) 2007-05-01 US claimed
US-20040194231-A1 Composition for dyeing keratin fibers comprising a defined triheteroylmethane direct dye or leuco precursor of this dye and dyeing method using it L'OREAL S.A. (FR) 2004-10-07 US claimed
US-20130129648-A1 SILICONE BASED COSMETIC COMPOSITIONS AND USES THEREOF L'OREAL (FR) 2013-05-23 US disclosed
US-8163037-B2 Methods and kits for providing lift and then a permanent color to hair L'OREAL (FR) 2012-04-24 US disclosed
US-20110203605-A1 METHODS AND KITS FOR PROVIDING LIFT AND THEN A PERMANENT COLOR TO HAIR L'OREAL (FR) 2011-08-25 US disclosed
US-7611544-B2 Methods of artificially coloring hair L'OREAL S.A. (FR) 2009-11-03 US disclosed
US-20090074701-A1 METHODS OF ARTIFICIALLY COLORING HAIR L'OREAL S.A. (FR) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040194231-A1 Composition for dyeing keratin fibers comprising a defined triheteroylmethane direct dye or leuco precursor of this dye and dyeing method using it KRT18, KMO, KRTCAP2 MAPT 174/4885TP53 2041/4885KDM4E 936/4885
US-20090074701-A1 METHODS OF ARTIFICIALLY COLORING HAIR HDAC10, RARA, PRDM7 MAPT 2824/4885TP53 1613/4885KDM4E 936/4885
US-20110203605-A1 METHODS AND KITS FOR PROVIDING LIFT AND THEN A PERMANENT COLOR TO HAIR ALDH1A3, COXFA4L2, LDHB MAPT 3905/4885TP53 1239/4885KDM4E 2245/4885
US-20130129648-A1 SILICONE BASED COSMETIC COMPOSITIONS AND USES THEREOF SMS, SMOX, SRM MAPT 4047/4885TP53 310/4885KDM4E 327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.